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Introduction
Microglia is major immune effector cells in the central nervous system. Microglial activation is a common phenomenon that occurs when the brain is injured (Woodroofe et al., 1986; Giulian et al., 1991) . Activated microglia express inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2) and the pro-inflammatory cytokines, interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) (Giulian et al., 1986; Zielasek et al., 1992; Lee et al., 1993; Minghetti and Levi, 1995; Pyo et al., 1997; Pyo et al., 1998) . Recent studies indicate that microglial activation affects the progression of neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease (GonzalezScarano and Baltuch, 1999; Vila et al., 2001) . Such observations highlight the importance of understanding the processes regulating microglial activation.
In the injured brain, microglia can be activated by factors released from damaged cells and also by factors that infiltrate from the blood due to breakdown of the blood brain barrier. The glycospingolipid gangliosides are particularly rich in the neuronal membrane (Derry and Wolfe, 1967) , which can be released from damaged neurons into the extracellular space. Previously, we reported that gangliosides induce expression of inflammatory mediators such as TNF-α, iNOS and COX-2 in microglia (Pyo et al., 1999a; Kim et al., 2002) . Blood plasma proteins were found to participate in the activation of microglia; thrombin and plasminogen induce expression of inflammatory mediators in microglia (Ryu et al., 2000; Choi et al., 2003; Min et al., 2003) .
Many studies have been reported on the signaling pathways involved in microglial activation. Signaling molecules known to mediate activation by compounds such as lipopolysaccharide, gangliosides and thrombin include mitogen-activated protein kinase (MAPK), phospholipase C, protein kinase C and NF-κB (Pyo et al., 1998; Pyo et al., 1999a; Ryu et al., 2000) . The role of protein kinase A (PKA) in microglial activation has not been established. In this study, we examined the involvement of PKA in microglial activation induced by plasminogen and gangliosides.
M aterials and M ethods
C ell culture Primary microglia were cultured from the cerebral Protein kinase A m ediates m icroglial activation induced by plasm inogen and gangliosides cortices of 1-3 day-old Sprague Dawley rats as previously described (Giulian et al., 1986; Pyo et al., 1998) . Briefly, cortices were triturated into single cells in minimal essential media (Sigma, St. Louise, MO) containing 10% fetal bovine serum (Hyclone, Logan, UT) and seeded into 75 cm 2 T-flasks (0.5 hemisphere/flask). Two weeks later microglia were detached from flasks by mild shaking and applied to a nylon mesh to remove astrocyte and cell clumps. Microglia were seeded into plates or dishes and medium was replaced after one hour in order to remove unattached cells. The BV2 immortalized murine microglial cell line was provided by Dr. E. J. Choi (Korea University). BV2 cells were constructed by infecting primary microglia with a v-raf/v-myc oncogene-carrying retrovirus (J2), and show most morphological, phenotypical and functional properties of freshly isolated microglia (Blasi et al., 1990) . BV2 cells were cultured in Dulbecco's Modified Eagle Medium (Gibco, Grand Island, NY) supplemented with 5% fetal bovine serum (Hyclone).
Reverse transcription polym erase chain reaction (RT-PCR)
Total RNA was isolated using RNAzol TM B (TEL-TEST, Inc., Friendwood, TX), and cDNA was prepared using reverse transcriptase that originated from Avian Myeloblastosis Virus (TaKaRa, Otsu, Japan) according to the manufacturer's instructions. The sequences of PCR primers used for IL-1β, TNF-α, iNOS, GAPDH and actin gene amplifications are shown in Table 1 .
Protein kinase A activity assay
Cells were washed twice with cold phosphate-buffered saline, and then lysed in ice-cold lysis buffer (50 mM Tris-HCl, 0.1% Triton X-100) containing protease inhibitors (2 mM phenylmethylsulfonyl fluoride, 100 µg/ ml leupeptin, 10 µg/ml pepstatin, 1 µg/ml aprotinin, 2 mM EDTA). Lysates were incubated on ice for 20 min, then centrifuged at 10,000 g at 4 o C for 20 min, after which the supernatant was collected for assay. The assay mixture contained 5 µg supernatant protein, 50 mM Tris-HCl, 1 mM DTT, 10 mM MgCl2, 30 µM kemptide (PKA substrate, Calbiochem, La Jolla, CA), 25 mM β-glycerophosphate and 2 µCi [γ 32 P]-ATP. Negative and positive control incubations contained 10 µM PKI (a specific PKA inhibitor) and 5 µM cAMP, respectively. After 5 min incubation, the reaction mixtures were spotted onto phosphocellulose paper, the paper was then washed twice with 1% phosphoric acid and once in 100% ethanol. The radioactivity associated with paper-bound phosphorylated peptide was counted using a liquid scintillation counter.
M easurem ent of NF-κB and CREB Activation by electrophoresis m obility shift assay (EM SA )
EMSA was carried out as previously described (Pier et al., 1981; Ryu et al., 2000) . Briefly, BV2 (5×10 5 cells) were harvested and incubated on ice for 15 min in 900 µl of a hypotonic solution [10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol (DTT), 0.5 mM phenylmethylsulfonylfluoride (PMSF)] containing 0.5% nonidet P-40. Cells were centrifuged at 2,000 g for 10 min at 4 o C and the pellet (nuclear fraction) was collected. The nuclear fraction was resuspended in a buffer containing 20 mM HEPES, pH 7.9, 20% glycerol, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT and 1 mM PMSF, incubated on ice for 60 min with occasional gentle shaking, and then centrifuged at 10,000 g for 20 min. The crude nuclear proteins in the supernatant were collected and stored at -70 o C until use in EMSA. Synthetic oligonucleotides (Santacruz, California, US) containing the NF-κB binding sequence (5'-AGTTGAGGGGAGTTTCCCAGGC-3' and 3'-TCAACTCCCCTGAAAGGGTCCG-5') and the CREB binding sequence (5'-AGAGATTGCCTGACGTCAG-AGAGCTAG-3' and 3'-TATCTAACGGACTGCAGTCT-CTCGATC-5') were end-labeled using Klenow fragment and [γ-32 P]-dATP. The labeled DNA probe (approximately 0.2 ng) was incubated for 30 minutes with Table 1 . The sequences of IL-1β, TNF-α iNOS, GAPDH and actin PCR primers.
5'-TCACTGGGACAGCACAGAAT-3' 5'-TGTGTCTGCAGATGTGCTGA-3' Mouse Actin 5'-CATGTTTGAGACCTTCAACACCCC-3' 5'-GCCATCTCCTGCTCGAAGTCTAG-3' ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ 1 µg nuclear protein in a reaction mixture containing 8.5 mM EDTA, 8.5 mM EGTA, 8% glycerol, 0.1 mM ZnSO4, 50 µg/ml poly (dI-dC), 1 mM DTT, 0.3 mg/ml bovine serum albumin and 6 mM MgCl2. The reaction mixture was separated on an 8% polyacrylamide gel, after which the gel was dried and autoradiographed. To identify specific binding of labeled oligonucleotides to the nuclear protein, excess (×20) unlabeled oligonucleotide was added to control incubations.
Statistical analysis
Data were analyzed using the Statistical Package for Social Sciences 8.0 (SPSS Inc., Chicago, IL).
R esults
Protein kinase A (PKA) m ediates plasm inogeninduced m icroglial IL-1β, TN F-α and iNOS m RNA expression Previously, we found that plasminogen induces interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) mRNA expression in microglia (Min et al., 2003) . To examine whether PKA mediates microglial activation, we investigated the effect of PKA inhibitors, KT5720 and H89, on plasminogen-induced IL-1β, TNF-α and inducible nitric oxide synthase (iNOS) mRNA expression. We found that in primary cultured microglia, KT5720 and H89 significantly reduced plasminogen-induced IL-1β and TNF-α mRNA expression ( Figure 1A ). Similar results were obtained when using the BV2 mouse microglial cell line and KT5720 and H89 also reduced plasmignogen-induced iNOS mRNA expression ( Figure 1B ). Since PKA inhibitors reduced plasminogen-induced IL-1β, TNF-α and iNOS mRNA expression, we investigated whether plasminogen activated PKA. PKA was activated within 10 min of plasminogen addition, and that activity reached a peak after 30 min, after which it decreased ( Figure  1C ). These results suggest that plasminogen activated microglia via PKA-dependent pathways.
Plasm inogen regulates DNA binding activities of CREB and NF-κB via protein kinase A cAMP response element (CRE) and NF-κB binding sites exist in the promoter regions of genes encoding IL-1β, TNF-α and iNOS (Collart et al., 1990; Hiscott et al., 1993; Wong et al., 1996; Kinugawa et al., 1997; Stylianou and Saklatvala, 1998; Tsai et al., 2000; Chang et al., 2004) . Furthermore, plasminogen increases the DNA binding activities of CRE binding protein (CREB) and NF-κB (Min et al., 2003) . We examined whether PKA regulated CREB and NF-κB activation. We found that addition of KT5720 and H89 reduced plasminogen-stimulated CREB and NF-κB DNA binding activities (Figure 2 ). These results suggest that plasminogen increased CREB and NF-κB DNA binding activities through PKA-dependent pathways in microglia.
PKA m ediates gangliosides-induced m icroglial activation
Although we have previously published that gangliosides activate microglia via diverse signaling pathways (Pyo et al., 1999a; Kim et al., 2002; Min et al., in press) , the role of PKA in this activation has not been reported. We found that in primary cultured microglia, KT5720 and H89 reduced gangliosides-induced IL-1β, TNF-α and iNOS mRNA expression. (Figure 3A) . Furthermore, in BV2 cells, gangliosides activated PKA within 5 min, and activity decreased to basal levels after 30 min ( Figure 3B ). We also found that gangliosides increased CREB binding activity within 5 min. These results suggest that PKA positively regulates gangliosides-induced microglial activation.
D iscussion
Previously, we reported that plasminogen and gangliosides activate microglia (Pyo et al., 1999a; Kim et al., 2002; Min et al., 2003; Min et al., In press ). Microglial activation induced by these agents triggers diverse signal transduction pathways such as those involving reactive oxygen species, MAPK, PKC and JAK/STAT (Pyo et al., 1999a; Kim et al., 2002; Min et al., 2003; Min et al., In press ). In the present study, we show that the signaling molecule PKA is also involved in positive regulation of microglial activation since plasminogen and gangliosides activated PKA, and PKA inhibitors reduced plasminogen-and gangliosides-induced IL-1β, TNF-α and iNOS mRNA expression.
cAMP is a well-known second messenger that activates PKA. cAMP has been reported to either enhance or reduce iNOS expression depending on the stimuli and cell type. cAMP-elevating agents, including cAMP analogues, norepinephrine and prostaglandins, suppressed LPS-induced iNOS expression in rat microglia (Minghetti et al., 1997) , Kupper cells (Mustafa and Olson, 1998) and hepatocytes (Smith et al., 1997) . In contrast, cAMP induced iNOS expression in rat vascular smooth muscle cells and mesengial cells (Imai et al., 1994; Eberhardt et al., 1998) . In human monocytes, murine astrocytes and rat cardiac myocytes, iNOS expression was induced by beta-endorphin and proinflammatory cytokines that increase Figure 2 . PKA inhibitors reduce the DNA binding activity of CREB and NF-κB in plasminogen-treated microglia. BV2 cells were treated with 40 µg/ml plasminogen (Plg) for 5 min in the absence or presence of the PKA inhibitors, 5 µM H89 or 250 nM KT5720 (KT). Nuclear extracts were prepared and (A) CREB-and (B) NF-κB-specific oligonucleotide-protein complexes were detected using electrophoresis mobility shift assays. The values represent the normalized intensities of the CREB and NF-κB bands against intensities of control bands measured by Image Gauge technology. Data are representatives of three independent experiments. intracellular cAMP levels (Oddis et al., 1996; Burgher et al., 1997; Aymerich et al., 1998) . In microglia, we found that cAMP-elevating agents such as cholera toxin and dbcAMP enhanced beta-amyloid- (Pyo et al., 1999b) and LPS-induced NO release (data not shown). This differential effect of cAMP on iNOS expression may reflect different cell types and/or different stimulators. Furthermore, the duration and extent of intracellular cAMP increase and PKA activity may differentially regulate iNOS expression, even in the same cell type (Galea and Feinstein, 1999 ).
An increase in intracellular cAMP can induce the expression of many genes via PKA-mediated phosphorylation of transcription factors, such as the cAMP response element binding protein (CREB) (Chandra et al., 1995) . The promoter regions of genes encoding IL-1β, TNF-α and iNOS contain CREB binding sites (Stylianou and Saklatvala 1998; Galea and Feinstein, 1999; Tsai et al., 2000) . Therefore, PKA may regulate IL-1β, TNF-α and iNOS expression via CREB phosphorylation. In a previous study and this study, we showed that plasminogen and gangliosides enhanced CREB DNA binding activity ( Figure 3C , Min et al., 2003) . Furthermore, PKA inhibitors reduced plasminogen-induced CREB binding activity (Figure 2A) . Thus, we propose that CREB is a PKA target during plasminogen-and gangliosides-induced microglial activation.
NF-κB binding sites exist in the promoter regions of IL-1β, TNF-α and iNOS genes (Collart et al., 1990;  Figure 3. PKA mediates gangliosides-induced microglial activation. (A) Primary cultured microglia were treated with 50 µg/ml gangliosides (Gang) for 3 h in the absence or presence of 5 µM H89 or 250 nM KT5720 (KT). TNF-α, iNOS and IL-1β mRNA expression was determined using RT-PCR. (B) BV2 cells were treated with 50 µg/ml gangliosides for the indicated times and PKA activity measured. Values represent the mean ± SEM of three samples. (C) BV2 cells were treated with 50 µg/ml gangliosides for the indicated times. Nuclear extracts were prepared and CREB-specific oligonucleotide-protein complexes were detected using electrophoresis mobility shift assays. The excess amount of unlabeled oligonucleotide was added to the reaction mixture to determine specific binding of labeled oligonucleotides to the nuclear protein (×20). The values under the figures represent the normalized intensities of the TNF-α, iNOS and IL-1β bands against intensities of GAPDH bands (A) or normalized intensities of CREB bands against intensity of the control band (C) measured by Image Gauge technology. Data are representatives of three independent experiments. Hiscott et al., 1993; Xie et al., 1993; Chang et al., 2004) . NF-κB activation may be regulated by PKA since in J774 macrophage-like cells, H89 inhibited LPS-induced NF-κB activation (Muroi and Suzuki, 1993) . The results presented in the current study show that PKA inhibitors reduced NF-κB DNA binding activity in plasminogen-treated microglia ( Figure 2B ). Extracellular-signal regulated kinase (ERK) may be another target of PKA. In PC12 cells, PKA is required for sustained activation of ERK (York et al., 1998) . We previously reported that ERK mediates gangliosides-induced microglial activation since gangliosides activated ERK, and the ERK pathway inhibitor, PD98059, reduced gangliosides-induced NO release (Pyo et al., 1999a) . In the present study, we found that both KT5720 and H89 reduced ERK activation in gangliosides-treated microglia (data not shown). In conclusion, the current results suggest that PKA is a positive regulator of microglial activation. Furthermore, the data suggest PKA exerts this control by acting as an upstream regulator of CREB and NF-κB. 
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